Metastasis and Prognostic Factors in Hepatocellular Carcinoma

The liver malignancy hepatocellular carcinoma (HCC) frequently disseminates via a multistep cascade involving local invasion, intravasation, survival in the circulation, extravasation and colonisation at distant organs. Pulmonary and lymphatic spread are common, while bone metastases signify a particularly aggressive disease stage associated with osteolytic lesions, pathological fractures and neurological complications. Molecular mediators—including chemokine receptors such as CXCR4, tumour-derived extracellular vesicles carrying microRNAs and epigenetic regulators—establish a supportive pre-metastatic niche and drive colonisation. Prognostic factors range from clinical metrics (tumour size, vascular invasion, performance status) to biomarkers (serum alpha-fetoprotein, gene expression signatures and circulating microRNAs). Recent advances in imaging and liquid-biopsy approaches facilitate earlier detection of extrahepatic spread. Prognostic models, including nomograms and machine-learning algorithms, integrate these variables to stratify individual risk of metastasis and predict survival, thereby informing tailored therapeutic strategies that span local ablation, systemic targeted therapies and immunotherapies. A deeper understanding of tumour–host interactions and the bone microenvironment remains vital to improving global outcomes in HCC.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Metastasis and Prognostic Factors in Hepatocellular Carcinoma publication trend

The graph below shows the total number of articles in metastasis and prognostic factors in hepatocellular carcinoma across all publications each year (not limited to Nature Index journals).

Technical terms

Metastasis: The process by which cancer cells spread from the primary tumour to distant organs.

Extracellular vesicle: Membrane-bound particles released by cells that mediate intercellular communication.

Nomogram: A graphical representation that calculates the probability of a clinical event based on multiple variables.

Prognostic factor: A patient or tumour characteristic that independently predicts disease outcome.

Osteolysis: The pathological breakdown of bone tissue commonly seen in metastatic lesions.

References

1. Bone Lesion‐Derived Extracellular Vesicles Fuel Prometastatic Cascades in Hepatocellular Carcinoma by Transferring ALKBH5‐Targeting miR‐3190‐5p. Advanced Science (2023).
2. Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma. BMC Cancer (2020).
3. Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival. BMC Cancer (2009).
4. Emerging Perspectives of Bone Metastasis in Hepatocellular Carcinoma. Frontiers in Oncology (2022).
5. Development and validation of an ensemble machine-learning model for predicting early mortality among patients with bone metastases of hepatocellular carcinoma. Frontiers in Oncology (2023).